Acupuncture was found to be more effective for reducing chronic joint pain in hemophilia patients than transcutaneous…
Patricia Inácio, PhD
Patricia holds her PhD in cell biology from the University Nova de Lisboa, Portugal, and has served as an author on several research projects and fellowships, as well as major grant applications for European agencies. She also served as a PhD student research assistant in the Department of Microbiology & Immunology, Columbia University, New York, for which she was awarded a Luso-American Development Foundation (FLAD) fellowship.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Patricia Inácio, PhD
Preventive treatment with Hemlibra (emicizumab) improves health-related quality of life (HQRoL) in children with hemophilia A who develop…
Long-term treatment with Esperoct (turoctocog alfa pegol) prevented bleeding in one-fifth of children with severe hemophilia…
An upcoming episode of the TV series “Advancements,” hosted by Ted Danson, will be dedicated to current and future…
The National Hemophilia Foundation (NHF) has opened a grant program to support the local groups and chapters that work…
Starting factor VIII (FVIII) preventive therapy before the age of 2.5 years improves joint outcomes in young adults with…
Under-the-skin, preventive treatment with Dalcinonacog alfa (DalcA) led to sustained and protective levels of factor IX (FIX) in people with…
Europeans with severe hemophilia are largely satisfied with available treatments and able to maintain active lives, according to a survey…
Switching from on-demand to preventive treatment — or prophylaxis — significantly reduces bleeding in adults…
Blood visibly present in urine — called macroscopic hematuria — considerably increases the risk of hypertension in hemophilia…